SARS-CoV-2 prevalence in an asymptomatic cancer cohort - results and consequences for clinical routine | Radiation Oncology | Full Text

SARS-CoV-2 prevalence in an asymptomatic cancer cohort - results and consequences for clinical routine | Radiation Oncology | Full Text

SARS-CoV-2 prevalence in an asymptomatic cancer cohort - results and consequences for clinical routine

Starting in December 2019, the current pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) confronts the world with an unprecedented challenge. With no vaccine or drug being cur...

Authors:Sebastian Marschner, Stefanie Corradini, Josefine Rauch, Richard Zacharias, Ana Sujic, Julia Mayerle, Raluca Petru, Béatrice Grabein, Oliver T. Keppler, Edwin Boelke, Claus Belka and Maximilian Niyazi

Citation:Radiation Oncology 2020 15:165

Content type:Research

 

Published on: 9 July 2020

• ViewFull Text
 
• ViewPDF